UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Consider key factors when choosing expense tracking software, including compatibility, features, and security. Make an informed decision with our step-by-step guide.
20,557 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A growing crime trend links revenge plots to cryptocurrency payments. This article explains how digital money helped ...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
A mid-sized industrial company delivered a dramatic rally, with Powell Industries stock surges pushing shares up dram...
When a niche tech stock makes a big leap, investors want to know why. This deep dive explains the factors behind IPG ...
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
As downsizing gains pace, a hidden Medicare surcharge could erase gains from selling the family home. Here’s what ret...
When OppFi shares their Q4 2025 earnings, investors want clarity on profitability, credit quality, and growth. This g...
A landmark revenue milestone meets a strategic investment push. This article breaks down why the billboard giant’s $1...
Florida once drew nonstop investor attention. A survey from Redfin says that momentum is cooling, reshaping how buyer...
Rivian’s April milestone could reshape its growth path. This article breaks down why April could huge for Rivian, wha...
Chase has cut credit-card limits for some customers with minimal usage, raising questions about credit-score impact a...